Chapter-specific guidelines (ICD-10-CM chapters 1-10)

CHAPTER 4


Chapter-specific guidelines (ICD-10-CM chapters 1-10)





Certain infectious and parasitic diseases


Chapter 1 in the I-10 Tabular is Certain Infectious and Parasitic Diseases (A00-B99), which classifies diseases according to the etiology (cause) of the disease. Because infectious and parasitic conditions can affect various parts of the body, the chapter contains a wide variety of codes and complex terminology.


In this chapter there are many instances of combination coding and multiple coding. Remember: Combination coding is when one code fully describes the conditions and/or manifestations. Multiple coding is when it takes more than one code to fully describe the condition, circumstance, or manifestation, and then sequencing of multiple codes is considered.





A codes (a00-a99)


The A codes include the blocks illustrated in Figure 4–1.



Antibiotics are used to kill the bacteria that cause disease, but many antibiotics that were historically effective against bacteria are no longer effective. Most bacteria have become resistant to some antibiotics, but other bacteria are resistant to many antibiotics (multiresistant organisms, MROs, or superbugs). Those antibiotics that have been widely prescribed are no longer effective—for example, methicillin-resistant Staphylococcus aureus (MRSA), multi-drug-resistant Mycobacterium tuberculosis (MDR-TB), and vancomycin-resistant Enterococcus (VRE). Penicillin-resistant Streptococcus pneumonia has also increased worldwide. When reporting an infection that is antibiotic resistant, report the infection first followed by Z16 (Infection with drug-resistant microorganism). This is the mechanism by which drug-resistant microorganisms are tracked. Staphylococcus aureus is the exception to the Z16 rule. For Staphylococcus aureus, specific codes designate the status of resistance to methicillin:



MSSA and MRSA infections are reported elsewhere in ICD-10 as well for some system-specific infections like pneumonia.




Sepsis, severe sepsis, and septic shock


SIRS is an inflammatory condition, also known as systemic inflammatory response syndrome. The inflammation is a response to microorganisms in the tissue, blood, lungs, skin, or urinary system. SIRS is diagnosed when two or more of the following are present:



SIRS is classified as severe sepsis when there is organ dysfunction, hypotension, or collection of fluids in the tissues (hypoperfusion). To report severe sepsis, you would report an R65.2x code but remember that severe sepsis can only be reported if severe sepsis is documented in the patient health record. The provider will make the diagnosis of SIRS. If the documentation indicates that the patient has SIRS and organ dysfunction and that the organ dysfunction is related to a condition other than SIRS, severe sepsis is not reported. There must be a documented correlation between the SIRS and the organ dysfunction to report severe sepsis. It will require at least three codes to report severe sepsis: a code for the underlying systemic infection, an R65.2x code, and a code or codes to report organ dysfunction. When the microorganism is not documented, report A41.9, Sepsis, unspecified.


Septic shock is a circulatory failure that represents a type of organ dysfunction. Report the underlying infection first, followed by R65.21, Severe sepsis with septic shock, and codes for any organ dysfunction documented in the health record. Code R65.21 is never assigned as the first-listed diagnosis because it is a result of an underlying infection; therefore, the infection is the first-listed diagnosis followed by the severe sepsis.



ICD-10 OFFICIAL GUIDELINES FOR CODING AND REPORTING



SECTION I.C. 1.d. Sepsis, severe sepsis, and septic shock




2) Septic shock



3) Sequencing of severe sepsis



SIRS may develop as a result of a procedure and becomes a complication of the medical care the patient received. In these instances, report a postprocedural infection first, followed by a code for the specific infection.




ICD-10 OFFICIAL GUIDELINES FOR CODING AND REPORTING



SECTION I.C. 1.d. Sepsis, severe sepsis, and septic shock




1) Coding of Sepsis and Severe Sepsis



(a) Sepsis



For a diagnosis of sepsis, assign the appropriate code for the underlying systemic infection. If the type of infection or causal organism is not further specified, assign code A41.9, Sepsis, unspecified organism.


A code from subcategory R65.2, Severe sepsis, should not be assigned unless severe sepsis or an associated acute organ dysfunction is documented.


(i) Negative or inconclusive blood cultures and sepsis



(ii) Urosepsis



(iii) Sepsis with organ dysfunction



(iv) Acute organ dysfunction that is not clearly associated with the sepsis



(b) Severe sepsis



4) Sepsis and severe sepsis with a localized infection



5) Sepsis due to a postprocedural infection





6) Sepsis and severe sepsis associated with a noninfectious process (condition)



In some cases a noninfectious process (condition), such as trauma, may lead to an infection which can result in sepsis or severe sepsis. If sepsis or severe sepsis is documented as associated with a noninfectious condition, such as a burn or serious injury, and this condition meets the definition for principal diagnosis, the code for the noninfectious condition should be sequenced first, followed by the code for the resulting infection. If severe sepsis, is present a code from subcategory R65.2 should also be assigned with any associated organ dysfunction(s) codes. It is not necessary to assign a code from subcategory R65.1, Systemic inflammatory response syndrome (SIRS) of non-infectious origin, for these cases.


If the infection meets the definition of principal diagnosis it should be sequenced before the non-infectious condition. When both the associated non-infectious condition and the infection meet the definition of principal diagnosis either may be assigned as principal diagnosis.


Only one code from category R65, Symptoms and signs specifically associated with systemic inflammation and infection, should be assigned. Therefore, when a non-infectious condition leads to an infection resulting in severe sepsis, assign the appropriate code from subcategory R65.2, Severe sepsis. Do not additionally assign a code from subcategory R65.1, Systemic inflammatory response syndrome (SIRS) of non-infectious origin.


See Section I.C.18. SIRS due to non-infectious process





Viral hepatitis


Viral hepatitis is reported with codes in the B15-B19 range, which are divided based on with or without hepatic coma and the type of hepatitis. For example, B15 reports acute hepatitis A and B16 reports acute hepatitis B.



 Hepatitis A (HAV) was formerly called epidemic, infectious, short-incubation, or acute catarrhal jaundice hepatitis, and the primary transmission mode is the oral–fecal route.


 Hepatitis B (HBV) was formerly called long-incubation period, serum, or homologous serum hepatitis. Transmission modes are through blood from infected persons and from body fluids of infected mother to neonate.


 Hepatitis C (HCV), caused by the hepatitis C virus and is primarily transfusion associated.


 Hepatitis D (HDV), also called delta hepatitis and is caused by the hepatitis D virus in patients formerly or currently infected with hepatitis B.


 Hepatitis E (HEV) is also called enterically transmitted non-A, non-B hepatitis. The primary transmission mode is the oral–fecal route, usually through contaminated water.




Human immunodeficiency


B20 reports human immunodeficiency virus diseases and includes AIDS (acquired immune deficiency syndrome), which is caused by HIV (human immunodeficiency virus). HIV affects certain white blood cells (T-4 lymphocytes) and destroys the ability of the cells to fight infections, making patients susceptible to a host of infectious diseases (e.g., Pneumocystis carinii pneumonia [PCP], Kaposi’s sarcoma, and lymphoma). AIDS-related complex (ARC) is an early stage of AIDS in which tests for HIV are positive but the symptoms are mild. Additional code(s) are reported to identify all the manifestations of the HIV infection. It is extremely important that only confirmed HIV cases are reported. The assignment of the HIV code prior to confirmation may cause the patient many unwarranted problems if the patient does not have HIV. Confirmation does not mean that a serology or culture for HIV is positive, but rather that the physician has documented that the patient is HIV positive or has HIV-related illnesses.


If the encounter is for an HIV-related condition, the first-listed diagnosis is B20 with additional codes to report the HIV-related condition(s). If the encounter is for an HIV-disease patient for other than the HIV or an HIV-related condition, the reason for the encounter is the first-listed diagnosis followed by B20. There are times when a patient is documented to be HIV-positive based on serology or culture but has no symptoms. Report this asymptomatic HIV status with Z21, Asymptomatic HIV status. However, once a patient has AIDS, report B20; never report R75 (inconclusive) or Z21 (asymptomatic). If the patient is known to have been exposed to HIV but has not tested positive for HIV and has no HIV symptoms, report Z20.6. If the serology for HIV is inconclusive, report R75.


If an HIV-positive patient is pregnant and the encounter is for an HIV-related illness, the first-listed diagnosis is O98.7, HIV disease complicating pregnancy, childbirth, and the puerperium, followed by B20 and codes for the HIV-related illness. If the patient’s status is asymptomatic HIV, report O98.7 and Z21 (asymptomatic HIV).


If the patient presents for HIV testing, report Z11.4, Encounter for screening for HIV. Additional codes may be assigned for any known high-risk behavior, such as:



If the patient has signs or symptoms when presenting for HIV screening, report the signs and symptoms and if counseling is provided during the encounter, report Z71.7, HIV counseling. When the patient returns for the results of the HIV screening and the results are negative, report Z71.7.



ICD-10 OFFICIAL GUIDELINES FOR CODING AND REPORTING


SECTION I.C.1. Chapter 1: certain infectious and parasitic diseases (a00-b99)




a. Human Immunodeficiency Virus (HIV) Infections



1) Code only confirmed cases 



2) Selection and sequencing of HIV codes



(a) Patient admitted for HIV-related condition



(b) Patient with HIV disease admitted for unrelated condition



(c) Whether the patient is newly diagnosed



(d) Asymptomatic human immunodeficiency virus



(e) Patients with inconclusive HIV serology



(f) Previously diagnosed HIV-related illness



(Note from author: State laws may have rules for coding and submitting AIDS diagnosis. Example: Under New York State Law, confidential HIV-related information can only be given to people the patient allows to have it by signing a written release or to people who need to know the HIV status in order to provide medical care and services.)



(g) HIV Infection in Pregnancy, Childbirth and the Puerperium



(h) Encounters for testing for HIV





Neoplasms


Chapter 2 of the I-10 contains codes C00-D49 to report neoplasms. There are extensive Guidelines that must be understood and followed to correctly code neoplasms.



ICD-10 OFFICIAL GUIDELINES FOR CODING AND REPORTING


SECTION I.C.2. Chapter 2: neoplasms (C00-D49)


General guidelines


Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms, such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary (metastatic) sites should also be determined.


Primary malignant neoplasms overlapping site boundaries


A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 (‘overlapping lesion’), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.


Malignant neoplasm of ectopic tissue


Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).


The neoplasm table in the Alphabetic Index should be referenced first. However, if the histological term is documented, that term should be referenced first, rather than going immediately to the Neoplasm Table, in order to determine which column in the Neoplasm Table is appropriate. For example, if the documentation indicates “adenoma,” refer to the term in the Alphabetic Index to review the entries under this term and the instructional note to “see also neoplasm, by site, benign.” The table provides the proper code based on the type of neoplasm and the site. It is important to select the proper column in the table that corresponds to the type of neoplasm. The Tabular List should then be referenced to verify that the correct code has been selected from the table and that a more specific site code does not exist.


See Section I.C.21. Factors influencing health status and contact with health services, Status, for information regarding Z15.0, codes for genetic susceptibility to cancer.



a. Treatment directed at the malignancy



b. Treatment of secondary site



c. Coding and sequencing of complications



Coding and sequencing of complications associated with the malignancies or with the therapy thereof are subject to the following guidelines:



1) Anemia associated with malignancy



2) Anemia associated with chemotherapy, immunotherapy and radiation therapy



3) Management of dehydration due to the malignancy



4) Treatment of a complication resulting from a surgical procedure



d. Primary malignancy previously excised



e. Admissions/Encounters involving chemotherapy, immunotherapy and radiation therapy



1) Episode of care involves surgical removal of neoplasm



2) Patient admission/encounter solely for administration of chemotherapy, immunotherapy and radiation therapy



3) Patient admitted for radiation therapy, chemotherapy or immunotherapy and develops complications



When a patient is admitted for the purpose of radiotherapy, immunotherapy or chemotherapy and develops complications such as uncontrolled nausea and vomiting or dehydration, the principal or first-listed diagnosis is Z51.0, Encounter for antineoplastic radiation therapy, or Z51.11, Encounter for antineoplastic chemotherapy, or Z51.12, Encounter for antineoplastic immunotherapy followed by any codes for the complications.



f. Admission/encounter to determine extent of malignancy



g. Symptoms, signs, and abnormal findings listed in Chapter 18 associated with neoplasms



h. Admission/encounter for pain control/management



i. Malignancy in two or more noncontiguous sites



j. Disseminated malignant neoplasm, unspecified



k. Malignant neoplasm without specification of site



l. Sequencing of neoplasm codes



1) Encounter for treatment of primary malignancy



2) Encounter for treatment of secondary malignancy



3) Malignant neoplasm in a pregnant patient



4) Encounter for complication associated with a neoplasm



5) Complication from surgical procedure for treatment of a neoplasm



6) Pathologic fracture due to a neoplasm



m. Current malignancy versus personal history of malignancy



n. Leukemia, Multiple Myeloma, and Malignant Plasma Cell Neoplasms in remission versus personal history



o. Aftercare following surgery for neoplasm



p. Follow-up care for completed treatment of a malignancy



q. Prophylactic organ removal for prevention of malignancy



r. Malignant neoplasm associated with transplanted organ



Apr 17, 2017 | Posted by in NURSING | Comments Off on Chapter-specific guidelines (ICD-10-CM chapters 1-10)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access